NM_001367534.1:c.875G>C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001367534.1(CAMK2G):c.875G>C(p.Arg292Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001367534.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAMK2G | NM_001367534.1 | c.875G>C | p.Arg292Pro | missense_variant | Exon 11 of 23 | ENST00000423381.6 | NP_001354463.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual developmental disorder 59 Pathogenic:2
The de novo heterozygous p.Arg292Pro missense variant identified in the CAMK2G gene has been reported in at least two unrelated patients affected with a neurological disorder [PMID: 23033978; PMID: 28191890; PMID: 30184290]. The variant has been reported as likely pathogenic in the ClinVar database [variation ID:39975]. The variant is absent from gnomAD(v3) database suggesting it is an extremely rare allele in the populations represented in this database. In vivoand in vitro functional analysis showed that the p.Arg292Pro variant exerts it’s pathogenic effect through gain-of-function mechanism via increased phosphotransferase activity, impaired neuronal maturation and impaired targeting of nuclear isoform [PMID: 30184290]. Based on the available evidence, the de novo p.Arg292Pro missense variant identified in the CAMK2G gene is reported here as Pathogenic. -
Variant confirmed as disease-causing by referring clinical team -
Autism;C0036857:Intellectual disability, severe;C0557874:Global developmental delay;C1858120:Generalized hypotonia Pathogenic:1
Parental studies indicated that this alteration is de novo in this individual. This alteration has been previously reported in the Human Gene Mutation Database and is associated with sporadic global developmental delay, hypotonia, and speech delay (GeneMatcher communication and de Ligt et al. (2012) N. Engl. J. Med. 367(20):1921-1929). This variant is not listed in the public SNP databases (ExAC, gnomAD) and is predicted to be deleterious or possibly damaging by multiple in silico algorithms (LRT, SIFT, PROVEAN, PolyPhen2-HumDiv). Based on the ACMG Guidelines for variant interpretation, using the criteria PS2, PS4 (downgraded to moderate), PM2, and PP3, this variant is classified as likely pathogenic. -
Intellectual disability, severe Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at